Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Carlo Ganini

Showing results (1-10 of 30) with videos related to

Pageof 3
Sort By:
Urologia|November 15, 2011
Surgery and target agents for renal cell carcinoma treatment: the path between proper interactionCarlo Ganini, Bruno Rovereto, Camillo Porta
Cell Death Discovery|March 21, 2020
The role of noncoding RNAs in epithelial cancerMassimiliano Agostini, Carlo Ganini, Eleonora Candi, et al.
Journal of Cancer|July 1, 2011
Immunological effects of multikinase inhibitors for kidney cancer: a clue for integration with cellular therapies?Camillo Porta, Chiara Paglino, Ilaria Imarisio, et al.
Journal of Nephrology|October 15, 2024
Management of cytotoxic chemotherapy in patients undergoing dialysis: a still unresolved issue of onconephrologyMarta Pirovano, Carlo Ganini, Maurizio Gallieni, et al.
Future Oncology (London, England)|August 17, 2012
The effect of sorafenib treatment on the diabetic status of patients with renal cell or hepatocellular carcinomaIlaria Imarisio, Chiara Paglino, Carlo Ganini, et al.
Anti-Cancer Agents in Medicinal Chemistry|July 23, 2013
Orai1 and transient receptor potential channels as novel molecular targets to impair tumor neovascularization in renal cell carcinoma and other malignanciesFrancesco Moccia, Silvia Dragoni, Valentina Poletto, et al.
Expert Review of Anticancer Therapy|June 3, 2015
Tivantinib (ARQ197) in hepatocellular carcinomaCamillo Porta, Palma Giglione, Alessandra Ferrari, et al.
Giornale Italiano Di Nefrologia : Organo Ufficiale Della Societa Italiana Di Nefrologia|November 26, 2023
[The Treatment of Metastatic Renal Cell Carcinoma: An Update]Gaetano Pezzicoli, Carlo Ganini, Giulia Vanessa Re Sartò, et al.
Future Oncology (London, England)|December 13, 2012
Sunitinib in advanced metastatic non-clear cell renal cell carcinoma: a single institution retrospective studyChiara Paglino, Ilaria Imarisio, Carlo Ganini, et al.
Cancer Treatment Reviews|April 15, 2023
Clinico-pathological implications of the 2022 WHO Renal Cell Carcinoma classificationMimma Rizzo, Anna Caliò, Matteo Brunelli, et al.
Pageof 3

Showing results (1-10 of 30) with videos related to

Sort By:
Pageof 3
Urologia|November 15, 2011
Surgery and target agents for renal cell carcinoma treatment: the path between proper interactionCarlo Ganini, Bruno Rovereto, Camillo Porta
Cell Death Discovery|March 21, 2020
The role of noncoding RNAs in epithelial cancerMassimiliano Agostini, Carlo Ganini, Eleonora Candi, et al.
Journal of Cancer|July 1, 2011
Immunological effects of multikinase inhibitors for kidney cancer: a clue for integration with cellular therapies?Camillo Porta, Chiara Paglino, Ilaria Imarisio, et al.
Journal of Nephrology|October 15, 2024
Management of cytotoxic chemotherapy in patients undergoing dialysis: a still unresolved issue of onconephrologyMarta Pirovano, Carlo Ganini, Maurizio Gallieni, et al.
Future Oncology (London, England)|August 17, 2012
The effect of sorafenib treatment on the diabetic status of patients with renal cell or hepatocellular carcinomaIlaria Imarisio, Chiara Paglino, Carlo Ganini, et al.
Anti-Cancer Agents in Medicinal Chemistry|July 23, 2013
Orai1 and transient receptor potential channels as novel molecular targets to impair tumor neovascularization in renal cell carcinoma and other malignanciesFrancesco Moccia, Silvia Dragoni, Valentina Poletto, et al.
Expert Review of Anticancer Therapy|June 3, 2015
Tivantinib (ARQ197) in hepatocellular carcinomaCamillo Porta, Palma Giglione, Alessandra Ferrari, et al.
Giornale Italiano Di Nefrologia : Organo Ufficiale Della Societa Italiana Di Nefrologia|November 26, 2023
[The Treatment of Metastatic Renal Cell Carcinoma: An Update]Gaetano Pezzicoli, Carlo Ganini, Giulia Vanessa Re Sartò, et al.
Future Oncology (London, England)|December 13, 2012
Sunitinib in advanced metastatic non-clear cell renal cell carcinoma: a single institution retrospective studyChiara Paglino, Ilaria Imarisio, Carlo Ganini, et al.
Cancer Treatment Reviews|April 15, 2023
Clinico-pathological implications of the 2022 WHO Renal Cell Carcinoma classificationMimma Rizzo, Anna Caliò, Matteo Brunelli, et al.
Pageof 3